BioSpace News Archive

Olympus announced that its iTind™ procedure for the treatment of enlarged prostate won Gold in the 2022 Medical Design Excellence Awards and Silver in the 2022 Edison Awards.

Following the launch of QUVIVIQ™ CIV on May 2, Idorsia Pharmaceuticals, U.S. Inc. announced that the first wave of patients has been prescribed the product through a pharmacy services provider.

aTyr Pharma, Inc. announced that the Compensation Committee of aTyr’s Board of Directors has granted four employees nonstatutory stock options to purchase an aggregate of 113,400 shares of its common stock, each with an exercise price of $3.48 per share, which is equal to the closing price of aTyr’s common stock on the Nasdaq Capital Market on May 10, 2022, the effective date of the grants.

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2022.

BAILI-BIOPHARMACEUTICAL CO., LTD. (“Baili”) and its wholly owned subsidiary, SystImmune, Inc (“SystImmune”), announced today that it has entered into a clinical trial collaboration and supply agreement with AstraZeneca.

MaxCyte, Inc. announced that, on May 10, 2022, the Compensation Committee of MaxCyte’s Board of Directors granted stock options to purchase an aggregate of 73,700 shares of MaxCyte’s common stock to six newly hired employees.

Scientific Industries, Inc., a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it will file a Form 10Q for its financial results for the period ended March 31, 2022, after the market close on Monday, May 16, 2022.

The U.S. Food and Drug Administration (FDA) approved Mounjaro™ (tirzepatide) injection, Eli Lilly and Company’s (NYSE: LLY) new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Nutex Health Inc. announced fiscal year 2022 1st Quarter financial results for the three months ended March 31, 2022 for the pre-merger Company.

Albany NY, United States: Smart biopsy devices help in distinguishing the healthy cells or calluses present in the tumorous cells of the body and helps in assisting surgeon in cancer therapy and cancer diagnosis.